Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT)-Reference-Cited by-同舟云学术

Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT)

Published:1999-11 Issue:5 Volume:138 Page:968-975
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Tamai Hideo,Katoh Osamu,Suzuki Shin,Fujii Kenshi,Aizawa Tadanori,Takase Shin-ichi,Kurogane Hiroyuki,Nishikawa Hideo,Sone Takahito,Sakai Kazuyoshi,Suzuki Takahiko

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute;Holmes;Am J Cardiol,1984

2. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients;Nobuyoshi;J Am Coll Cardiol,1988

3. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months;Serruys;Circulation,1988

4. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: results of the randomized, double-blind STARC study;Maresta;Circulation,1994

5. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty;Eriksen;Am Heart J,1995

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit;International Immunopharmacology;2024-08

2. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities;Nature Metabolism;2024-03-26

3. Inflammasomes as Potential Therapeutic Targets in Atherosclerotic Cardiovascular Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

4. Role of Cardiac Fibroblasts in Cardiac Injury and Repair;Current Cardiology Reports;2022-01-13

5. Nanomicelle-generating Microneedles Loaded With Tranilast for Treatment of Hypertrophic Scars in a Rabbit Model;In Vivo;2022